Africa CDC wants local vaccine manufacturing
In this Friday, June 19, 2020, a woman wearing a face mask passes a coronavirus billboard carrying a message in a bid to prevent the spread of the virus. (AP File Photo/Themba Hadebe/File)
JOHANNESBURG — As the first wave of the coronavirus pandemic crashes across Africa, the head of the Africa Centers for Disease Control and Prevention said the intellectual property from any effective vaccine should be made available for local manufacturing and swifter distribution.
John Nkengasong also told reporters that Africa’s 1.3 billion people have “all kinds of differences in genetic makeup, so we want to be sure that we are participating fully” in vaccine trials.
Africa has had more than 644,000 confirmed virus cases, nearly half in South Africa alone.
Concerns are widespread that any successful vaccine will be snapped up by richer countries and that Africa will be last in line, an echo of the time when it took years for affordable HIV drugs to become available.
The Africa CDC chief said the continent has more than 80 potential clinical trial sites with the ability to enroll participants and monitor them carefully. He also warned that “we are in for a long, long journey” in this pandemic.
For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.
